R&D Systems™ Recombinant Human BTNL8 Fc Chimera Biotinylated Protein, CF

Catalog No.	Quantity
BT9359050	50 μg

Catalog No. BT9359050 Supplier R&D Systems™ Supplier No. BT9359050

Description

Learn More About B7-related Butryophilins as Immune Modulators View Webinar

Measured by its ability to enhance anti-CD3-induced IFN-gamma secretion of mouse CD3+ T cells. The ED50 for this effect is 0.5-2.5 μg/mL.

Specifications

• Accession Number: Q6UX41-1
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 79908
• Molecular Weight (g/mol): M.W. (Observed): 56-63 kDa and 100 - 160 kDa, reducing conditions; M.W. (theoretical): 52 kDa (unlabeled)
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human BTNL8 protein Human BTNL8 (Gln18-Lys238) (N-terminus) Accession # Q6U x 41-1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Biotin
• Cross Reactivity: BTNL8
• Species: Human
• Reconstitution: Reconstitute at 200 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BTNL8